Saturday, January 14, 2017 8:31:36 AM
http://pitchbook.com/profiles/novotyr-therapeutics-profile-investors-funding-valuation-and-analysis
Details
http://www.firstwordpharma.com/node/29233?tsid=17#axzz4VjzLPNqB
- Teva invested $1 million in Novotyr Therapeutics and has an option to invest several million dollars more for a 27 percent stake in the company, Globes online reported today.
- Novotyr is developing inhibitors of an insulin-like growth factor receptor as drugs for the treatment of cancer and other diseases. The company plans to begin clinical trials in 2009.
Novotyr was the previously name of Tyrnovo.
Still have to do some DD about, but looks like there is Teva behind Novotyr and his illuminated co-founder Alexander Levitzki (where he served ad Member of Scientific Advisory Board).
http://www.bloomberg.com/research/stocks/people/person.asp?personId=6313122&capId=6313094&previousCapId=6700309&previousTitle=United%20States%20Department%20Of%20Agriculture
Waiting for PR where Management can explain this new strategy.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM